BHC — Bausch Health Companies Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 885590 ·
Last close
$4.78
Market Cap
$1.79B
52W High
$6.29
52W Low
$4.57
ADV30
2,732,798
Next earnings
2026-07-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,524,000,000 | 1,786,000,000 | 521,000,000 | -1,423,000,000 | 24,498,000,000 | 1,299,000,000 | 25,580,000,000 |
| Dec 2025 | 2,796,000,000 | 1,998,000,000 | 829,000,000 | -112,000,000 | 26,366,000,000 | 1,309,000,000 | 25,989,000,000 |
| Sep 2025 | 2,681,000,000 | 1,931,000,000 | 636,000,000 | 179,000,000 | 26,824,000,000 | 1,308,000,000 | 26,468,000,000 |
| Jun 2025 | 2,530,000,000 | 1,766,000,000 | 457,000,000 | 148,000,000 | 27,266,000,000 | 1,727,000,000 | 27,119,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,419,000,000
Investing CF
$-604,000,000
Financing CF
$-696,000,000
CapEx
$-430,000,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-3.24
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-11,090,000,000
Inventory
$1,601,000,000
Receivables
$2,191,000,000
ST Investments
—
EBIT TTM
$736,000,000
Pretax Income TTM
$-940,000,000
Interest Exp TTM
$1,676,000,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$10,531,000,320
EBITDA
$3,614,000,128
Free Cash Flow
$1,123,500,032
Enterprise Value
$22,288,091,136
Total Cash
$1,299,000,064
Total Debt
$20,795,000,832
Shares Out
373,475,644
Trailing EPS
$-3.24
Book Value
$-5.51
ROE
—
ROA
5.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,266,000,000 | 2,185,000,000 | 157,000,000 | 26,366,000,000 | 25,989,000,000 | — | 1,400,000,000 |
| Dec 2024 | 9,625,000,000 | 1,854,000,000 | -46,000,000 | 26,523,000,000 | 26,845,000,000 | — | 1,597,000,000 |
| Dec 2023 | 8,757,000,000 | 1,600,000,000 | -592,000,000 | 27,350,000,000 | 27,432,000,000 | — | 1,032,000,000 |
| Dec 2022 | 8,124,000,000 | 1,391,000,000 | -225,000,000 | 25,686,000,000 | 25,426,000,000 | — | -728,000,000 |
TTM Snapshot
Revenues TTM
$8,905,000,000
NetIncome TTM
$124,000,000
OpCashFlow TTM
$0
Assets (Latest)
$26,523,000,000
Forward EPS
$4.22
Max Pain — expiry 2026-07-17
max pain strike: $5.50 · spot: $4.78 · call oi: 11,253 · put oi: 5,794
Expected Move to 2026-07-17:
±$0.35
(7.32%) —
implied range
$4.43 –
$5.13
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | $1.81B | $28.74 | — |
| DMRA | Damora Therapeutics, Inc. | $1.76B | $28.53 | — |
| GHRS | GH Research PLC | $1.82B | $26.51 | — |
| GENB | Generate Biomedicines, Inc. | $1.84B | $14.32 | — |
| CMPS | COMPASS Pathways plc | $1.84B | $13.64 | — |
News headlines (Yahoo Finance, 1h cache)
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
2026-07-07 11:00 · Yahoo
Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia
2026-07-06 11:00 · Yahoo
Michael Goettler Resigns from Bausch Health's Board of Directors
2026-07-01 20:15 · Yahoo
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for t
2026-06-09 12:00 · Yahoo
Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?
2026-05-29 15:30 · Yahoo
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China
2026-05-28 20:15 · Yahoo
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals
2026-05-21 13:02 · Yahoo
Bausch Health Announces 2026 Annual Meeting of Shareholder Results
2026-05-19 20:15 · Yahoo
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth
2026-05-18 09:00 · Yahoo
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference
2026-05-13 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.